202 related articles for article (PubMed ID: 35924839)
21. The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
Whitfield MG; Warren RM; Mathys V; Scott L; De Vos E; Stevens W; Streicher EM; Groenen G; Sirgel FA; Van Rie A
J Antimicrob Chemother; 2018 Oct; 73(10):2667-2674. PubMed ID: 29982641
[TBL] [Abstract][Full Text] [Related]
22. Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
ElMaraachli W; Slater M; Berrada ZL; Lin SY; Catanzaro A; Desmond E; Rodrigues C; Victor TC; Crudu V; Gler MT; Rodwell TC
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1222-6. PubMed ID: 26459537
[TBL] [Abstract][Full Text] [Related]
23. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.
Ocheretina O; Escuyer VE; Mabou MM; Royal-Mardi G; Collins S; Vilbrun SC; Pape JW; Fitzgerald DW
PLoS One; 2014; 9(3):e90569. PubMed ID: 24599230
[TBL] [Abstract][Full Text] [Related]
24. Disputed
Lin WH; Lee WT; Tsai HY; Jou R
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0157320. PubMed ID: 33846134
[TBL] [Abstract][Full Text] [Related]
25. Molecular detection of rifabutin-susceptible Mycobacterium tuberculosis.
Chen HY; Yu MC; Huang WL; Wu MH; Chang YL; Che CR; Jou R
J Clin Microbiol; 2012 Jun; 50(6):2085-8. PubMed ID: 22442316
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of rpoB gene mutation in MTB detected isolates in a tertiary care centre (AGMC) of North-East, India.
Majumdar T; Banik A; Allada V; Das B
Indian J Med Microbiol; 2023; 45():100399. PubMed ID: 37573058
[TBL] [Abstract][Full Text] [Related]
27. Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
Getahun M; Blumberg HM; Ameni G; Beyene D; Kempker RR
PLoS One; 2022; 17(9):e0274426. PubMed ID: 36099255
[TBL] [Abstract][Full Text] [Related]
28. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF
Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277
[TBL] [Abstract][Full Text] [Related]
29. Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible
Hasan Z; Razzak SA; Kanji A; Shakoor S; Hasan R
Int J Mycobacteriol; 2023; 12(2):179-183. PubMed ID: 37338481
[TBL] [Abstract][Full Text] [Related]
30. Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.
de Vos M; Müller B; Borrell S; Black PA; van Helden PD; Warren RM; Gagneux S; Victor TC
Antimicrob Agents Chemother; 2013 Feb; 57(2):827-32. PubMed ID: 23208709
[TBL] [Abstract][Full Text] [Related]
31. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
[TBL] [Abstract][Full Text] [Related]
32. Mutation analysis of mycobacterial rpoB genes and rifampin resistance using recombinant Mycobacterium smegmatis.
Nakata N; Kai M; Makino M
Antimicrob Agents Chemother; 2012 Apr; 56(4):2008-13. PubMed ID: 22252831
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
[TBL] [Abstract][Full Text] [Related]
34. Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease.
Beckler DR; Elwasila S; Ghobrial G; Valentine JF; Naser SA
World J Gastroenterol; 2008 May; 14(17):2723-30. PubMed ID: 18461657
[TBL] [Abstract][Full Text] [Related]
35. Mutations of
Tavanaee Sani A; Ashna H; Kaffash A; Khaledi A; Ghazvini K
Ethiop J Health Sci; 2018 May; 28(3):299-304. PubMed ID: 29983529
[TBL] [Abstract][Full Text] [Related]
36. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of codon 548 in the rpoB gene involved in Mycobacterium tuberculosis resistance to rifampin.
Horng YT; Jeng WY; Chen YY; Liu CH; Dou HY; Lee JJ; Chang KC; Chien CC; Soo PC
Antimicrob Agents Chemother; 2015 Mar; 59(3):1542-8. PubMed ID: 25534743
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan.
Chien HP; Yu MC; Ong TF; Lin TP; Luh KT
J Formos Med Assoc; 2000 May; 99(5):408-11. PubMed ID: 10870331
[TBL] [Abstract][Full Text] [Related]
39. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia.
Sintchenko V; Chew WK; Jelfs PJ; Gilbert GL
Pathology; 1999 Aug; 31(3):257-60. PubMed ID: 10503273
[TBL] [Abstract][Full Text] [Related]
40. Rifabutin Resistance Associated with Double Mutations in
Jing W; Pang Y; Zong Z; Wang J; Guo R; Huo F; Jiang G; Ma Y; Huang H; Chu N
Front Microbiol; 2017; 8():1768. PubMed ID: 28959248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
